Scholar
IQ
Help
Try ScholarIQ free
Home
Papers
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
Upload Records
Snowball Search
Search OpenAlex
About the database
ScholarIQ
answers from OpenAlex
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
Paper
Citations, authors & open-access status
3,413
Citations
2,017
Year
bronze
OA Status
IDs:
DOI
PMID
OpenAlex
Related on ScholarIQ
Howard Gurney
Author
Toni K. Choueiri
Author
New England Journal of Medicine
Journal
Bladder and Urothelial Cancer Treatments
Topic
Bladder and Urothelial Cancer Treatments
Topic
Cancer Immunotherapy and Biomarkers
Topic
470M+ articles · free account